baber/WOPTO huggingface dataset:
Patent NZ-519749-A (NZ)
Title: Process for the production of filled food hollow mouldings
Inventor: STEIN VON KAMIENSKI BOTHO
IPC: A23L7/191
Filed: 2000-12-15
Abstract: A method for producing filled foodstuff hollow bodies is described. Each hollow body has at least one cavity which opens out onto the surrounding area and is filled with solid filling material at an ambient temperature. The cavity has a cross-sectional area of between 0.24 mm<2> and 1 cm<2>. In a first step the hollow bodies are coated with the filling material at a reduced pressure and at a temperature that the filling material is a flowable fluid. The pressure is increased in a second step so that the coating material can enter the cavity.
Patent NZ-522320-A (NZ)
Title: In vitro modification of glycosylation patterns of recombinant glycopeptides
Inventor: BAYER ROBERT J
IPC: C12N9/10
Filed: 2001-05-14
Abstract: Methods for modifying glycosylation patterns of glycopeptides, including recombinantly produced glycopeptides. Also provided are glycopeptide compositions in which the glycopeptides have a uniform glycosylation pattern.
Patent NZ-522764-A (NZ)
Title: Front axle air suspension
Inventor: STUART JOHN W
IPC: B60G9/00
Filed: 2001-05-11
Abstract: A front axle suspension having on each side of a vehicle a spring beam pivotally attached at its fore or front end to a bracket depending from a chassis frame side beam with its aft or trailing end mounted on the vehicle front axle. An assembly of integrated parts serves to resiliently support each chassis frame side beam on the spring beam and axle below. A key part of each assembly is a multi-functional component having a central body portion mounted on the trailing end of the spring beam which has: (1) fore-and-aft spring support formations projecting in cantilever relationship from its fore and aft sides; (2) seats for the bight portions of U-bolts located inwardly of the spring support formations; (3) a laterally projecting shock absorber mount on its front wheel facing side; and (4) a track rod attachment bracket projecting laterally from its vehicle center facing. In addition each assembly has: (1) U-bolts extending downwardly from the U-bolt seats on opposite sides of the axle; and (2) a shock absorber pivotally attached on its lower end on the shock absorber mount with its upper end pivotally attached to a laterally projecting mount on the outer side of the chassis frame side beam. A track rod is pivotally attached at one end to the track rod attachment bracket and pivotally attached at its opposite end to a bracket mounted on the inner side of the opposing chassis frame side beam.
Patent NZ-525084-A (NZ)
Title: N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
IPC: A61K31/16
Filed: 2003-04-01
Abstract: The compound R(-)-2-[(4-isobutyl)phenyl]propionamide which is suitable for use as an inhibitor of neutrophil chemotaxis and degranulation induced by interleukin 8.
Patent NZ-526990-A (NZ)
Title: Process for the synthesis of LHRH peptide analogs using a solid phase
Inventor: JACKSON STEVEN ALLEN
IPC: C07K7/23
Filed: 2001-12-19
Abstract: A process for making a LHRH peptide having the formula pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2, wherein the indole-NH of any Trp residue is protected comprises: (a) attaching a cesium-salt of Boc-Gly or Boc-Pro onto a chloromethylated polystyrene resin to yield Boc-Gly-resin; (b) deblocking Boc-Gly-rsin by mixing the Boc-Gly-resin with a mixture of a Boc-deblocking organic acid to yield an organic acid salt of H2N-Gly-resin (c) neutralizing the organic acid salt of H2N-Gly-resin with a base to yield H2N-Gly-resin (d) coupling H2N-Gly-resin with a Boc-alpha-amine protected amino acid; and (e) cleaving and deprotecting the protected completed peptide-resin to the yield the peptide. Also described is the solid phase synthesis of the peptides the tryptophan residues can be protected with a side chain protecting group which is labile to a base.
Patent NZ-527015-A (NZ)
Title: Power tool with integral gripping member
Inventor: COOPER VINCENT P
IPC: B25F5/02
Filed: 2003-07-15
Abstract: A power tool (10) has a housing (12) with at least one aperture (40) in the housing. A gripping member (32) is positioned with respect to the outer surface of the housing such that the gripping member is contacted by a user when the power tool is used. At least one member is coupled with the gripping member. The at least one member extends through the at least one housing aperture to enable the gripping member to be positioned with respect to the outer surface of the housing.
Patent NZ-528261-A (NZ)
Title: Air-distribution cap for a convector
Inventor: RIELLO VALERIO GIORDANO
IPC: F24F1/00
Filed: 2001-03-20
Abstract: The present invention relates to an air-distribution cap which is to be fitted on top of a heating or air-conditioning unit with natural or forced convection and the function of which is to regulate both the flow-rate and the direction of the air output by the convector. In particular, the present invention relates to a cap for distributing the air output by a heating or air-conditioning unit with forced convection or with natural convection, characterized in that it comprises a deflector having one or more vanes, each vane being orientable so as to adopt a position in which it is inclined to the vertical so that its outer end faces towards the wall against which the unit is fitted.
Patent NZ-530426-A (NZ)
Title: Door for closing the operative inner space of a drink distributing machine
Inventor: SPAGNA DANILO
Filed: 2001-06-21
Abstract: A door (2) for closing the operative space of a cup drink distributing machine (1) comprising: a back part facing said operative space and an opposed front part. To the door (2) are associated means for filling cups, means for driving the cups to a dispensing space, a shell (4) for holding and containing said filling and cup driving means, lighting means (8) for illuminating at least a substantially light-transparent portion (5) of the door front surface. Advantageously, the holding shell (4) comprises a partition (9) for dividing the shell in a front portion (10) for receiving said lighting means (8) and in back portion (11) for receiving said filling and cup driving means, the front portion of the shell being substantially light-transparent and being faced to said at least a substantially light-transparent portion (5) of the front surface of the door (2).
Patent NZ-531562-A (NZ)
Title: Gaming machine with prize building feature based on number selection
Inventor: FONG COLIN
IPC: G06F19/00
Filed: 2004-03-04
Abstract: A gaming machine has a display and a game controller arranged to control images of symbols displayed on the display. The game controller is arranged to play a game wherein at least one random event is caused to be displayed on the display means and, if a predefined winning event occurs, the machine awards a prize. The game comprises a bonus feature in which at least one meter, having a plurality of number positions, is displayed on the display and, by a predetermined selection process, a number from a set of numbers is selected and associated with at least one number position of the at least one meter. A decision as to which number position of the at least one meter is to be filled by which of the numbers from the set is made by the game controller, and completion of filling of the number positions of the at least one meter provides an indication of a prize won by a player.
Patent NZ-532257-A (NZ)
Title: A chilling device and insulation therefor
Inventor: NAISMITH GEOFF CHARLES
IPC: A47F3/04
Filed: 2004-04-08
Abstract: A chilling device comprises a base member (16), an outer sleeve (27), an inner sleeve (25) and a top member (18), the inner sleeve defining a chillable space, chilling means (32) between the outer sleeve and the inner sleeve for circulating chilled air around an air gap between the outer sleeve and the inner sleeve. In one form, the inner sleeve is three sided, the fourth side of the chillable space being defined by the chilling means arranged within the outer sleeve. Also disclosed are novel insulating panels adapted to be positioned within the space between the inner sleeve and the outer sleeve.
Patent NZ-532533-A (NZ)
Title: Controlled release structure for attaching medical devices
Inventor: CAIZZA RICHARD J
IPC: A61B17/20
Filed: 2004-04-26
Abstract: A medical device for use with a fluid transfer device having a frusto-conically-shaped tip includes a hub having an open proximal end with a frusto-conically-shaped cavity therein, a distal end and a passageway therethrough. The cavity is part of the passageway. A release element in the passageway of the hub is positioned to block fluid-tight engagement of the frusto-conically-shaped tip with the cavity of the hub. Structure is provided to release at least part of the release element, upon application of a proximally directed force on the hub, to allow the abrupt fluid-tight engagement of the tip and the cavity in the hub.
Patent NZ-532792-A (NZ)
Title: A dimensionally stable anode for the electrowinning of aluminium
Inventor: JULSRUD STEIN
IPC: C25C3/12
Filed: 2002-09-25
Abstract: An anode for the electrolysis of aluminium made from an outer dense layer of a ceramic material on a dense core made from a composite of the ceramic material of the outer layer and an electronic conductor.
Patent NZ-532993-A (NZ)
Title: Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
Inventor: QUALLICH GEORGE JOSEPH
IPC: A61P25/28
Filed: 2002-11-25
Abstract: Disclosed is the citrate salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one, as represented by formula (I). The citrate salt compound is used as an antagonist of the serotonin-1D (5-HT1d) receptor.
Patent NZ-534660-A (NZ)
Title: 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
Inventor: BLUME THORSTEN
IPC: A61P37/08
Filed: 2003-01-17
Abstract: Benzimidazole derivatives of formula (I), the production and use thereof in the treatment and prophylaxis of diseases that are associated with microglial activation, and of T-cell mediated immunological diseases. The invention also relates to the pharmaceutical preparations that contain the benzimidazole derivatives.
Patent NZ-536061-A (NZ)
Title: Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
Inventor: JOHNSTONE TIMOTHY B C
IPC: C07D401/12
Filed: 2003-05-12
Abstract: Disclosed is a substituted quinolone carboxylic acid compound having the Formula I or a pharmaceutically acceptable salt, or solvate thereof, wherein the substituents are disclosed within the specification. Also disclosed is the use of the above compound of formula I or a pharmaceutically acceptable salt there of in the manufacture of a medicament for the treatment of disorders relating to learning and memory, stress related disorders, depression, seizure disorders, insomnia and chronic pain.
Patent NZ-537158-A (NZ)
Title: Apparatus and method for exposing comminuted foodstuff to a processing fluid
Inventor: ROTH ELDON
IPC: A23G9/20
Filed: 2003-06-18
Abstract: An apparatus (40) for exposing comminuted foodstuffs to a fluid is disclosed. The apparatus has contactor body formed by two components (41/42) including a foodstuff flow passage. The foodstuff flow passage extends from the contactor body inlet end (44) to the contactor body outlet end (45). A portion of the foodstuff flow passage (46) is a contact passage (46), surrounding which is a processing fluid chamber (49). The processing fluid chamber (49) is divided in to a number of fluid chambers (61). The fluid chambers (61) includes an outer surface, spaced apart from an inner surface of the contact passage (56), so as to define an annular contact flow area having a minimum transverse dimension smaller than a minimum transverse dimension of the inlet flow area. There is a fluid communication arrangement providing fluid communication between the fluid chambers (61) and the contact passage (46) as well as a supply tube providing a fluid path (64) from a point outside of the contactor body to the interior of the processing fluid chamber (49).
Patent NZ-537200-A (NZ)
Title: Indole piperidine derivatives useful as histamine H3 antagonists
Inventor: ASLANIAN ROBERT G
IPC: A61P11/00
Filed: 2003-06-20
Abstract: Disclosed is a compound represented by the structural formula I or a pharmaceutically acceptable salt or solvate thereof, wherein: a is 0 to 3; b is 0 to 3; n is 2; p is 1,2 or 3; r is 0,1 or 2; X is a bond or C1-C6 alkylene; M1 is N; M2 is C(R3); with the proviso that the sum of p and r is 3; Y is -C(=O)-, -C(=S)-, -(CH2)q-, -C(=O)NR4-, -C(=O)CH2-, -SO1-2- or -C(=N-CN)-NH-; q is 1 to 5; Z is a bond, C1-C6 alkylene, C2-C6 alkenylene, -C(=O)-, -CH(CN)- or -CH2C(=O)NR4-; the dotted line represents an optional double bond; R2 is a six-membered heteroaryl ring having 1 or 2 heteroatoms independently selected from N or N-O, with the remaining ring atoms being carbon; a five- membered heteroaryl ring having 1,2, 3 or 4 heteroatoms independently selected from N, O or S, with the remaining ring atoms being carbon; R32-quinolyl; R32-aryl; or heterocycloalkyl; wherein said six-membered heteroaryl ring or said five-membered heteroaryl ring is optionally substituted by R6; R3 is H, halogen, C1-C6 alkyl, -OH or (C1-C6)alkoxy; R12 is independently selected from the group consisting of C1-C6 alkyl, hydroxyl, C1-C6 alkoxy, or fluoro, provided that when R12 is hydroxy or fluoro, then R12 is not bound to a carbon adjacent to a nitrogen; or R12 forms a C1 to C2 alkyl bridge from one ring carbon to another ring carbon; R13 is independently selected from the group consisting of C1-C6 alkyl, hydroxyl, C1-C6 alkoxy, or fluoro, provided that when R13 is hydroxy or fluoro then R13 is not bound to a carbon adjacent to a nitrogen; or forms a C1 to C2 alkyl bridge from one ring carbon to another ring carbon; or R13 is =O; R1 is an indole or indolene group as defined in the specification; and other substitutents are as defined in the specification. The compounds are histamine H3 antagonists and may be used in the manufacture of medicaments for the treatment of, for example, allergy, allergy-induced airway responses and congestion.
Patent NZ-539025-A (NZ)
Title: Telemedicine system
Inventor: TARASSENKO LIONEL
IPC: G06F19/00
Filed: 2003-09-18
Abstract: A telemedicine system for monitoring chronic conditions such as asthma or diabetes includes an electronic measurement device such as an electronic peak expiratory flow meter or an electronic blood glucose meter, connected to a GPRS cellular telephone. The cellular telephone automatically receives, formats and transmits the data on acquisition by the medical device to a remote server. The server may acknowledge the data and make the data available to a clinician. The server may also analyse the data and provide automatic alerts to the patient and/or clinician in the event of the data causing concern. The formatting and transmission of the data from the telephone to the server occurs in real time as the measurements are taken and is invisible to the patient.
Patent NZ-540481-A (NZ)
Title: A device for preparing an undifferentiated cell
Inventor: ABULJADAYEL IIHAM MOHAMED SALEH SAEED
IPC: A61K35/12
Filed: 2001-05-10
Abstract: Provided is a device for farming and/or increasing the relative number of undifferentiated cells in a cell population including committed cells, which device comprises a chamber, means for introducing into said chamber a cell population including committed cells, means for introducing into said chamber an agent that causes the committed cell to retrodifferentiate into an undifferentiated cell, and incubation means for incubating said agent and said committed cells such that a committed cell retrodifferentiates into an undifferentiated cell, and measuring means for measuring the volume of said cell population, means for conducting cell counts and for measuring the cell concentration of said cell populations and calculator means for calculating the volume of the agent to be added to the chamber, the volume of the agent being dependent on both volume and cell concentration of the cell population.
Patent NZ-549901-A (NZ)
Title: Therapeutic light-emitting device
Inventor: SAMUEL IFOR DAVID WILLIAM
IPC: A61N5/06
Filed: 2002-11-15
Abstract: An ambulatory device for use in photodynamic therapy, the device comprising an electromagnetic radiation source, attachment means for attaching the electromagnetic radiation source to a patient and control means for activating and deactivating the source to cause the latter to emit a succession of light pulses for activating a photodynamic chemical, whilst reducing the effects of photobleaching on the chemical.
Patent NZ-552456-A (NZ)
Title: Seal for controlled evacuation ostomy appliance
Inventor: DAVIES GERAINT
Filed: 2007-01-05
Abstract: A controlled evacuation ostomy appliance comprises a membrane that is urged into sealing engagement with a stoma, by the generation of radial tension in the membrane. A tensioning device applies tension, with respect to the stoma, at one or more positions that are (i) outboard of the periphery of the projecting portion of the stoma, and/or (ii) between the level of the peristomal skin and the level of the most projecting part of the stoma. Tension limiting means are disclosed. The membrane may be gas-permeable to allow flatus to be vented.
Patent NZ-554384-A (NZ)
Title: Drive mechanism for drug delivery device
Inventor: SAIKI MASARU
IPC: A61M5/315
Filed: 2005-09-14
Abstract: Disclosed is a drive mechanism for a drug delivery device. The drive mechanism includes a hollow plunger rod having a non-circular cross section and a plunger rod holder which engages with and prevents the plunger rod from rotating or moving towards a proximal end of the drug delivery device during dose setting. The plunger rod holder allows the plunger rod to move towards a distal end of the drug delivery device during dose dispensing. The drive mechanism further includes a lead screw engaged with the plunger rod and a dose setting dial rotatably movable towards the proximal end during dose setting and rotatably movable towards the distal end during dose dispensing. The drive mechanism also includes an inner cylinder which is releasably connected to the dose setting dial such that relative rotation between the dose setting dial and the inner cylinder is prevented during dose setting but is allowed during dose dispensing.
Patent NZ-556367-A (NZ)
Title: Bidirectional data transfer optimization and content control for networks
Inventor: SHEFFI GUY
IPC: G06F15/16
Filed: 2005-12-08
Abstract: An apparatus for transferring data objects over a network is disclosed. The apparatus includes at a sending locality on the network an interception unit which intercepts and caches passing objects on the way to respective recipients; and an associated identification unit, which generates respective unique identifiers for respective passing objects. The interception unit also replaces the respective passing objects with the respective unique identifiers to pass over the network and uses the respective unique identifiers to label the respective passing objects in the cache. The apparatus includes at a receiving locality on the network: a search unit which searches for a corresponding object in at least one node dictionary using the respective unique identifier to identify the corresponding object, and supplies the corresponding object to a respective recipient from a relatively nearby node dictionary without carrying out redundant network transfer.
Patent NZ-565961-A (NZ)
Title: Newcastle disease virus-like particles as vaccines for paramyxovirus
Inventor: MORRISON TRUDY G
IPC: A61K39/12
Filed: 2006-08-03
Abstract: Disclosed is a vaccine comprising Newcastle disease virus-like particles, said particles comprising a Newcastle disease viral matrix protein. The disclosed vaccine is used in the manufacture of a medicament for immunizing a host susceptible to Newcastle disease with said vaccine under conditions such that antibodies directed to said virus-like particle are produced. Also encompassed by the specification is a method, comprising; a) providing, i. an expression vector comprising DNA sequences encoding a Newcastle disease matrix protein; ii. a cell capable of being transfected by said vector; b) transfecting said cell with said vector under conditions such that Newcastle disease virus-like particles are generated, provided said cell is not within a human.
Patent NZ-575398-A (NZ)
Title: Vertical axis wind turbine with an added blade and method for its production
Inventor: SCHAAP ANTONIUS BERNARDUS
IPC: F03D3/00
Filed: 2007-09-20
Abstract: A vertical-axis wind turbine (1) and a method of manufacturing the turbine. The turbine has at least two Darrieus type turbine blades (3), and each Darrieus blade (3) is connected by a supporting arm (4, 4') and a tensile connector ( 5, 5') to the rotatable vertical axis of the turbine (2). An extra Savionius blade (6, 6') is added between the connector (5, 5') and the arm (4, 4'). The extra blade is convex at an angle of attack side and is concave at the other side, so that the added blades (6, 6') operate as Savionius rotors, allowing the turbine to easily start rotating.
Patent NZ-575628-A (NZ)
Title: Antimicrobial food packaging
Inventor: SCHIFFMANN JURGEN
IPC: A22C13/00
Filed: 2007-10-08
Abstract: A single- or multi-layered food packaging on the basis of plastic material, wherein the layer or at least one of the layers comprises at least one metal with antimicrobial activity, and at least part of the metal with antimicrobial activity is present in finely divided metallic form and the remaining part is present in the form of a salt. Also disclosed is a process to make said packaging the addition of colloidal metal during extrusion.
Patent NZ-575907-A (NZ)
Title: 5-substituted benzoxazines
Inventor: SHREDER KEVIN
IPC: A61K31/536
Filed: 2007-09-20
Abstract: Disclosed are benzoxazinones, or pharmaceutically acceptable salts thereof, of formula (I) wherein "A" is a 5-10 membered heteroaryl ring connected to the benzoxazine core by a carbon atom of the heterocyclyl or heteroaryl ring, and the other substituents are disclosed within the specification. Also disclosed is the use of the said compounds for the manufacture of pharmaceutical compositions for treating serine hydrolase-mediated diseases. Such diseases include pulmonary emphysema, acute respiratory distress syndrome, adult respiratory distress syndrome, idiopathic interstitial pneumonia, cystic pulmonary fibrosis, chronic interstitial pneumonia, chronic bronchitis, chronic sinopulmonary infection, diffuse panbronchiolitis, bronchiectasis, asthma, pancreatitis, nephritis, hepatic failure, chronic rheumatoid arthritis, joint scleroma, osteoarthritis, psoriasis, periodontitis, atherosclerosis, rejection against organ transplant, premature amniorrhexis, bullous dermatosis, shock, sepsis, systemic lupus erythematosus, Crohn's disease, disseminated intracapillary coagulation, tissue injury after ischemiareperfusion, formation of cornea cicatricial tissue and myelitis.